OccuLogix, Inc.
NASDAQ : RHEO
TSX : RHE

OccuLogix, Inc.

August 30, 2005 10:45 ET

OccuLogix to Present at ThinkEquity Partners 3rd Annual Growth Conference

TORONTO, ONTARIO--(CCNMatthews - Aug. 30, 2005) - OccuLogix, Inc. (NASDAQ:RHEO)(TSX:RHE) announced today that it will present at the ThinkEquity Partners 3rd Annual Growth Conference at the Ritz-Carlton Hotel in San Francisco, California on September 13 at 2:30 p.m. Pacific Time.

A slide and audio Webcast will be available live and archived for 90 days at the Investor Relations section of www.occulogix.com.

About OccuLogix, Inc.

OccuLogix is a health care company that brings innovative and evidenced-based medical therapies to market. OccuLogix's common shares trade on the NASDAQ National Market under the symbol 'RHEO' and on the Toronto Stock Exchange under the symbol 'RHE'.

Forward-Looking Statements

This press release may contain forward-looking statements. These statements relate to future events and are subject to risks, uncertainties and assumptions about the company. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Actual events or results may differ materially. Many factors may cause our actual results to differ materially from any forward-looking statement, including the factors detailed in our filings with the Securities and Exchange Commission and Canadian regulatory authorities, including our Registration Statement on Form S-1. We do not undertake to update any forward-looking statements.


Contact Information